Gennaio 2010 - Volume XXIX - numero 1

Medico e Bambino

Problemi correnti

Vaccino anti-morbillo-parotite-rosolia e allergia all’uovo
Finalmente una svolta epocale

Irene Berti, Giorgio Longo

Clinica Pediatrica, IRCCS “Burlo Garofolo”, Trieste

Indirizzo per corrispondenza:


Key words: Measles-mumps-rubella vaccine, Egg allergy, Anaphylaxis

Since measles and mumps components used in measles-mumps-rubella (MMR) vaccine are grown in cultures of fibroblast from chick embryos, the safety of administering MMR vaccine to patients allergic to eggs has been debated for long time. Finally international recommendations and Italian guide line clearly state that MMR vaccine do not contain significant amounts of egg cross-reacting proteins and so there are no risks for patients allergic to eggs. Furthermore, children with egg allergy are at low risk of allergic reaction to MMR, even if they have a history of severe anaphylaxis to egg ingestion: they can be vaccinated regularly, without previous skin test with the vaccine and the procedure does not need to be done in a hospital.

Vuoi citare questo contributo?

I. Berti, G. Longo
Vaccino anti-morbillo-parotite-rosolia e allergia all’uovo; Finalmente una svolta epocale
Medico e Bambino 2010;29(1):36-40

leggi l'articolo in formato PDF